Diffusion and Flux Improvement of Drugs through Complexation

MKC Mannava, A Garai, AK Nangia - Molecular Pharmaceutics, 2023 - ACS Publications
Improving the solubility and permeability of drugs via cocrystallization is an important theme
in crystal engineering with practical applications for the discovery and development of high …

Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions

DE Moseson, LS Taylor - Molecular Pharmaceutics, 2023 - ACS Publications
Does the performance of an amorphous solid dispersion rely on having 100% amorphous
content? What specifications are appropriate for crystalline content within an amorphous …

Particle Size, Dose, and Confinement Affect Passive Diffusion Flux through the Membrane Concentration Boundary Layer

PD Sinko, N Salehi, T Halseth, PJ Meyer… - Molecular …, 2023 - ACS Publications
The authors present a steady-state-, particle-size-, and dose-dependent dissolution–
permeation model that describes particle dissolution within the concentration boundary layer …

Quantitative Investigation of Intestinal Drug Absorption Enhancement by Drug-Rich Nanodroplets Generated via Liquid–Liquid Phase Separation

E Yoshikawa, K Ueda, R Hakata, K Higashi… - Molecular …, 2024 - ACS Publications
Drug-rich droplets formed through liquid–liquid phase separation (LLPS) have the potential
to enhance the oral absorption of drugs. This can be attributed to the diffusion of these …

Predicting nanocarrier permeation across the human intestine in vitro: Model matters

N Jung, J Schreiner, F Baur, S Vogel-Kindgen… - bioRxiv, 2024 - biorxiv.org
For clinical translation of oral nanocarriers, simulation of the complex intestinal
microenvironment is crucial to evaluate interactions and transport across the intestinal …

A PEGylated Nanocarrier for Oral Delivery of Immunomodulator Thymopentin

MM Liu - 2023 - researchspace.auckland.ac.nz
The oral delivery of drugs is the most popular route of administration for patients. However,
thymopentin (TP5) is only available in the market in forms for parenteral administration as an …